ImmunityBio Inc. (26CA)
XDUS
8.72
+0.09 (+1.04%)
Delayed Data
Oct 14, 2026, 06:00 AM
Day's Range
8.708.72
52 wk Range
1.7010.06
Financial Statements - 26CA - ImmunityBio Inc.
Revenue
113.28M▲ 668.3%
Net Income
-351.47M▲ 15.0%Net Margin -310.2%
EBITDA
-282.76M▲ 6.8%
Free Cash Flow
-309.18M▲ 22.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 113.28M | 14.74M | 622K | 240K | 934K | 605K |
| Cost of Goods | 753K | 0 | - | - | - | - |
| Gross Profit | 112.53M | 14.74M | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -256.02M | -344.18M | -361.36M | -350.61M | -330.28M | -210.22M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 14.25M | 82.46M | -94.19M | -5.86M | -5.54M | -8.46M |
| Pre Tax Income | -351.60M | -413.64M | -583.89M | -417.28M | -349.83M | -226.03M |
| Income Tax | -135K | 0 | -40K | 34K | 9K | -1.84M |
| Net Income | -351.47M | -413.64M | -583.85M | -417.32M | -349.84M | -224.18M |
| EPS Basic | -0.38 | -0.59 | -1.15 | -1.04 | -0.89 | -0.578974 |
| EPS Diluted | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 | -0.578974 |
| Basic Shares Outstanding | 919.86M | 697.31M | 533.36M | 416.18M | 405.08M | 398.78M |
| Diluted Shares Outstanding | 919.86M | 697.31M | 533.36M | 416.18M | 405.08M | 398.78M |
| Ebit | -239.08M | -281.98M | -454.69M | -353.77M | -334.99M | -216.95M |
| Ebitda | -282.76M | -303.44M | -387.96M | -342.49M | -315.81M | -194.27M |
| Net Income Continuous Operations | -351.47M | -413.64M | -583.85M | -417.32M | -349.84M | -224.18M |
| Minority Interests | 74K | 81K | 656K | 753K | 3.05M | 2.33M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
